Acurx Pharma's Phase 2b Study Of Ibezapolstat In C. Difficile Infection On Track

Acurx Announces Positive Microbiology And Microbiome Data For Ibezapolstat From Phase 2b Trial

Biopharmaceutical company Acurx Pharmaceuticals, Inc. (ACXP) announced Wednesday positive comparative microbiology and microbiome data for ibezapolstat, its lead antibiotic candidate, from its recently completed Phase 2b clinical trial in patients with Clostridoides difficile infection or CDI.

RTTNews | il y a 567

Acurx Pharma Discontinues Phase 2b Trial For Ibezapolstat To Treat C. Difficile Infection

Biopharmaceutical company Acurx Pharmaceuticals, Inc. (ACXP) announced Monday that the Company has discontinued the Phase 2b clinical trial of its lead antibiotic candidate, ibezapolstat, for the treatment of patients with Clostridioides difficile infection (CDI) due to success.

RTTNews | il y a 674

India Holds Key Interest Rates Steady As Trade Tensions Escalate

The Reserve Bank of India left its key interest rates unchanged on Wednesday after an aggressive cut in June as the economy faces another threat from the US due to its Russian oil imports. The RBI Monetary Policy Committee, led by Governor Sanjay Malhotra, unanimously decided to hold the policy repo rate at 5.50 percent. The bank had reduced the rate by 50 basis points in June.

RTTNews | il y a 2h 15min

Bay Street Looks Set To Extend Upmove

Canadian shares look headed for a positive start on Wednesday, riding on some impressive corporate earnings updates, and higher oil prices. The focus will also be on the developments on the trade front.

RTTNews | il y a 3h 43min

Eurozone Retail Sales Recover In June

Euro area retail sales rebounded in June suggesting that household spending likely supported economic growth in the second quarter, official data revealed on Wednesday. Retail sales grew 0.3 percent on a monthly basis in June, offsetting May's 0.3 percent decline, Eurostat said. However, this was marginally weaker than economists' forecast for a 0.4 percent increase.

RTTNews | il y a 3h 53min

Euro Rises As European Shares Traded Higher

The euro strengthened against other major currencies in the European session on Wednesday, as European shares traded higher despite weak factory orders data from Germany and fresh tariff threats from U.S. President Donald Trump on pharma and chips. Some upbeat earnings announcements and expectations of a Fed interest rate cut next month appear to be aiding sentiment.

RTTNews | il y a 4h 26min

Disney Lifts FY25 EPS View After Q3 Profit Beats Market; ESPN In Deal With WWE, NFL

Media and entertainment major Walt Disney Co. (DIS) on Wednesday raised fiscal 2025 outlook for earnings.above the Street after reporting significantly higher profit in its third quarter, above market estimates. Meanwhile, revenues missed the market view, despite reporting a growth. Separately, Disney announced that its unit ESPN has signed a landmark rights agreement with WWE.

RTTNews | il y a 4h 43min

Dynatrace Boosts FY26 Outlook - Update

While reporting financial results for the first quarter on Wednesday, software intelligence provider Dynatrace, Inc. (DT) provided its adjusted earnings and revenue guidance for the second quarter and raised its outlook for the full-year 2026.

RTTNews | il y a 4h 49min

EURUSD	1.16452	GBPUSD	1.33614	AUDUSD	0.65034
USDJPY	147.298	USDCAD	1.37421	USDCHF	0.80516

Advertisement

Acurx Pharma's Phase 2b Study Of Ibezapolstat In C. Difficile Infection On Track